BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 33562668)

  • 21. Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients.
    Dragoș ML; Ivanov IC; Mențel M; Văcărean-Trandafir IC; Sireteanu A; Titianu AA; Dăscălescu AS; Stache AB; Jitaru D; Gorgan DL
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma.
    Ziccheddu B; Da Vià MC; Lionetti M; Maeda A; Morlupi S; Dugo M; Todoerti K; Oliva S; D'Agostino M; Corradini P; Landgren O; Iorio F; Pettine L; Pompa A; Manzoni M; Baldini L; Neri A; Maura F; Bolli N
    Clin Cancer Res; 2021 Dec; 27(23):6479-6490. PubMed ID: 34526359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma.
    Kassambara A; Hose D; Moreaux J; Walker BA; Protopopov A; Reme T; Pellestor F; Pantesco V; Jauch A; Morgan G; Goldschmidt H; Klein B
    Haematologica; 2012 Apr; 97(4):622-30. PubMed ID: 22102711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma.
    Kosztolányi S; Kiss R; Atanesyan L; Gángó A; de Groot K; Steenkamer M; Jáksó P; Matolcsy A; Kajtár B; Pajor L; Szuhai K; Savola S; Bödör C; Alpár D
    J Mol Diagn; 2018 Nov; 20(6):777-788. PubMed ID: 30096382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.
    Kortuem KM; Braggio E; Bruins L; Barrio S; Shi CS; Zhu YX; Tibes R; Viswanatha D; Votruba P; Ahmann G; Fonseca R; Jedlowski P; Schlam I; Kumar S; Bergsagel PL; Stewart AK
    Blood Cancer J; 2016 Feb; 6(2):e397. PubMed ID: 26918361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
    Walker BA; Mavrommatis K; Wardell CP; Ashby TC; Bauer M; Davies FE; Rosenthal A; Wang H; Qu P; Hoering A; Samur M; Towfic F; Ortiz M; Flynt E; Yu Z; Yang Z; Rozelle D; Obenauer J; Trotter M; Auclair D; Keats J; Bolli N; Fulciniti M; Szalat R; Moreau P; Durie B; Stewart AK; Goldschmidt H; Raab MS; Einsele H; Sonneveld P; San Miguel J; Lonial S; Jackson GH; Anderson KC; Avet-Loiseau H; Munshi N; Thakurta A; Morgan GJ
    Blood; 2018 Aug; 132(6):587-597. PubMed ID: 29884741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
    Laganà A; Perumal D; Melnekoff D; Readhead B; Kidd BA; Leshchenko V; Kuo PY; Keats J; DeRome M; Yesil J; Auclair D; Lonial S; Chari A; Cho HJ; Barlogie B; Jagannath S; Dudley JT; Parekh S
    Leukemia; 2018 Jan; 32(1):120-130. PubMed ID: 28642592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the molecular biology of myeloma and its therapeutic implications.
    Boyd KD; Pawlyn C; Morgan GJ; Davies FE
    Expert Rev Hematol; 2012 Dec; 5(6):603-17. PubMed ID: 23216592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomics of Multiple Myeloma.
    Robiou du Pont S; Cleynen A; Fontan C; Attal M; Munshi N; Corre J; Avet-Loiseau H
    J Clin Oncol; 2017 Mar; 35(9):963-967. PubMed ID: 28297630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosomal and genetic abnormalities in myeloma.
    Joy Ho P
    Clin Lab Haematol; 2002 Oct; 24(5):259-69. PubMed ID: 12358886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytogenetic abnormalities in high-risk multiple myeloma].
    Ishida T
    Nihon Rinsho; 2015 Jan; 73(1):28-32. PubMed ID: 25626299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.
    Mikulasova A; Smetana J; Wayhelova M; Janyskova H; Sandecka V; Kufova Z; Almasi M; Jarkovsky J; Gregora E; Kessler P; Wrobel M; Walker BA; Wardell CP; Morgan GJ; Hajek R; Kuglik P
    Eur J Haematol; 2016 Dec; 97(6):568-575. PubMed ID: 27157252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing genomic discovery in newly diagnosed multiple myeloma: defining disease biology and its correlation to risk.
    Hagen P; Sellin M; Berg S; Zhang J
    Ann Hematol; 2022 Jul; 101(7):1407-1420. PubMed ID: 35585246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical impact of chromothriptic complex chromosomal rearrangements in newly diagnosed multiple myeloma.
    Kaur G; Gupta R; Mathur N; Rani L; Kumar L; Sharma A; Singh V; Gupta A; Sharma OD
    Leuk Res; 2019 Jan; 76():58-64. PubMed ID: 30576858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal Evolution in Multiple Myeloma.
    Fakhri B; Vij R
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S130-4. PubMed ID: 27521309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
    Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA
    Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.
    Rack K; Vidrequin S; Dargent JL
    J Clin Pathol; 2016 Jan; 69(1):82-6. PubMed ID: 26338801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma.
    Dutta AK; Hewett DR; Fink JL; Grady JP; Zannettino ACW
    Br J Haematol; 2017 Jul; 178(2):196-208. PubMed ID: 28466550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic stratification of multiple myeloma treated with novel agents.
    Jiang A; Reece D; Chang H
    Leuk Lymphoma; 2012 Feb; 53(2):202-7. PubMed ID: 21823830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent Cytogenetic Abnormalities in Multiple Myeloma.
    Chan NC; Chan NP
    Methods Mol Biol; 2017; 1541():295-302. PubMed ID: 27910031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.